Melvin AJ, Mohan KM, Schiffer JT, Drolette LM, Magaret A, Corey L, Wald A. Plasma and CSF herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr. 2015 Apr; 166(4):827-33.
• PubMed Abstract
Rajagopal S, Magaret A, Mugo N, Wald A. Incidence of herpes simplex virus type 2 infections in Africa: a systematic review. Open Forum Infect Dis. 2014 Jul 11; 1(2):ofu043.
• PubMed Abstract
Delaney S#, Gardella C, Saracino M, Magaret A, Wald A. Seroprevalence of herpes simplex virus type 1 and 2 among pregnant women, 1989-2010. JAMA (Research Letter) 2014 Aug 20; 312(7):746-8.
• PubMed Abstract
Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L, Stoelben S, Huang ML, Selke S, Stobernack HP, Ruebsamen-Schaeff H, Birkmann A. Helicase-Primase Inhibitor Pritelivir for Herpes Simplex Virus 2 Infection. N Eng J Med 2014; 370:201-210.
• PubMed Abstract
Perti T, Saracino M, Baeten J, Johnston C, Diem K, Ochbamichael N, Huang ML, Selke S, Magaret A, Corey L, Wald A. High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomized, crossover trial. J Acquir Immune Dfic Syndr. 2013; 63(2):201-8.
• PubMed Abstract
Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 2012 Feb 18; 379(9816):641-7.
• Lancet Abstract
Printer-friendly